DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits

您当前的位置：

首页 >

文章列表页 >

DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits

REVIEW | 更新时间：2023-05-10

上一篇|下一篇

- DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
- DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
- Michael Razavi ，Ying-Ying Wei ，Xiao-Quan Rao ，Ji-Xin Zhong
- Military Medical Research 2023年10卷第2期页码：227-241
- 作者机构：
  1.Tulane University School of Medicine, New Orleans, LA 70112, USA
  2.Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan 430032, China
  3.Department of Cardiovascular Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan 430032, China
  4.Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430032, China
- 作者简介：
  * xqrao@tjh.tjmu.edu.cn;
  zhongjixin620@163.com
- 基金信息：
  the National Natural Science Foundation of China(81974254;31870906;82170470)
- DOI： 10.1186/s40779-022-00410-2
  中图分类号：
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
图( 2 ) 表( 3 )
参考文献
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

39

浏览量

25

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

相关文章

Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Frostbite: diagnosis, treatment, prognosis, and future directions

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance

相关作者

暂无数据

相关机构

暂无数据